Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Agnes
Agnes Bajza, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20090214677 | Pharmaceutical Composition Containing an Extract of a Solidago Species - An extract of a part of a | 08-27-2009 |
Agnes Barouh, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20080295929 | Storage Bag - The invention concerns a bag ( | 12-04-2008 |
Agnes Bonvilain, Francin FR
| Patent application number | Description | Published |
|---|---|---|
| 20110124955 | DEVICE TO PREVENT URINARY LEAKAGE - The invention concerns a device to prevent urinary leakage intended to be implanted in a patient, comprising: | 05-26-2011 |
Agnes Bonvilain, Myans FR
| Patent application number | Description | Published |
|---|---|---|
| 20110137330 | SURGICAL INTERVENTION DEVICE COMPRISING AN INSTRUMENT LIKELY TO DEFORM - The disclosure relates to a surgical intervention device, including a surgical instrument capable of passing through human or animal tissue and a system comprising so-called “passive” components capable of measuring deformation or a local strain of the instrument and/or so-called “active” components capable of imposing a local strain on the instrument, the system comprising at least two series of passive components arranged at the surface of the instrument so as to establish a biunivocal relation between the position of the instrument or the position of the distal end of the instrument and all the data originating from the series, and, where required, at least two series of active components arranged at the surface of the instrument. The disclosure also relates to a process for determining the position of the distal end of a surgical instrument capable of passing through human or animal tissue. | 06-09-2011 |
Agnes Cadavid Labrada, Santiago CL
| Patent application number | Description | Published |
|---|---|---|
| 20080216194 | METHOD TO PRODUCE STERILE MALE FLOWERS AND PARTENOCARPIC FRUITS BY GENETIC SILENCING, ASSOCIATED SEQUENCES AND VECTORS CONTAINING SAID SEQUENCES - Genes VvPI from | 09-04-2008 |
Agnes Csiszar, Niederzier DE
| Patent application number | Description | Published |
|---|---|---|
| 20120100077 | MIXTURE OF AMPHIPATHIC MOLECULES AND METHOD FOR MODIFYING CELL MEMBRANES BY MEANS OF FUSION - Disclosed is a mixture of amphipathic molecules and a method for modifying cells in vivo by way of membrane fusion with these molecules. | 04-26-2012 |
Agnes Degeorges, Clermont-Ferrand FR
| Patent application number | Description | Published |
|---|---|---|
| 20110232819 | Tire for Heavy Vehicles Comprising at Least Two Additional Layers in the Beads - A tire with a radial carcass reinforcement comprising a crown reinforcement, itself radially capped by a tread strip, the said tread strip being connected to two beads via two sidewalls, the carcass reinforcement being anchored in each of the beads to form an anchorage region. The tire additionally comprises, in part of at least each of the anchorage regions, at least two layers formed by circumferential winding of a complex strip formed of two layers consisting of continuous reinforcing elements passing from one layer to the other, the said reinforcing elements being parallel within a layer and crossed from one layer to the other at angles with respect to the circumferential direction that are identical in terms of absolute value. | 09-29-2011 |
Agnes Delaunay, La Jolla, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100077491 | Modulators of RNF5 and Uses Thereof - Provided herein are compositions and methods relating to the involvement of RNF5 in muscle wasting. | 03-25-2010 |
Agnes De Leuze-Jallouli, St. Petersburg, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20090059383 | Process for Edging Optical Lenses - A process for edging an optical lens for conforming the optical lens to the size and shape of a lens frame into which the optical lens is to be accommodated, said process comprising: a) providing an optical lens having a convex surface, the convex surface being provided with an anti-smudge topcoat rendering the optical lens inappropriate for edging; b) fixing a mounting element on the convex surface of the optical lens, preferably on its center, by means of an adhesive pad adhering both to the mounting element and the convex surface of the optical lens to form a mounting element/optical lens assembly; c) placing the mounting element/optical lens assembly in a grinding machine so that the optical lens is firmly maintained; and d) edging the optical lens to the intended size and shape, wherein, prior to step (b) of fixing the mounting element, the anti-smudge topcoat on the convex surface of the optical lens is pre-treated with a solvent selected from the group consisting of alkanols and dialkylketones under a mechanical stress. | 03-05-2009 |
Agnes De Postel, Waly FR
| Patent application number | Description | Published |
|---|---|---|
| 20090182381 | Spinal Osteosynthesis Device and Preparation Method - A spinal internal implantation device for osteosynthesis has one or more bars for supporting for moving the spine and at least one implant for connecting the bars and vertebrae. The implant includes a blown anchor attached to a body of the implant and a fixation arrangement for the bars. The fixation arrangement includes a clamp for clamping the bar against internal walls of a channel formed in the body of the implant. At least part of the length of the bars includes a transversal bearing structure that is a cross-section of the bars having at least one flat part of a part having a lower forepost convexity than the rest of the cross section. | 07-16-2009 |
Agnes Derecskei-Kovacs, Gambrills, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20120103857 | Cylinder Surface Treatment For Monochlorosilane - The present invention is a container and a processing for passivating the internal surface of the container to store monochlorosilane in a stable manner without degradation of the monochlorosilane. Various container surface modifications have been identified to reduce surface reactions to acceptable levels. Some of the described surface modifications result in significant reduction in monochlorosilane instability. | 05-03-2012 |
Agnes Dimayuga, Mountain View, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110251930 | DATA MANAGEMENT FOR TOP-DOWN RISK BASED AUDIT APPROACH - Particular embodiments generally relate to providing risk management. In one embodiment, a first risk is linked to an account group assertion in a data structure. A second risk is linked to a control objective in the data structure. Access to the first risk is granted through the account group's assertion. Access to the second risk is granted through the control objective. Risk management is then performed using the accessed first risk and second risk. | 10-13-2011 |
Agnes Dupontfilliard, Les Adrets FR
| Patent application number | Description | Published |
|---|---|---|
| 20110250680 | AUTOMATED SYSTEM FOR THE LYSIS OF MICROORGANISMS PRESENT IN A SAMPLE, FOR EXTRACTION AND FOR PURIFICATION OF THE NUCLEIC ACIDS OF SAID MICROORGANISMS FOR PURPOSES OF ANALYSIS - The present invention relates to, among other things, a device for collecting airborne microorganisms, said device having: | 10-13-2011 |
Agnes Fonverne, Vizille FR
| Patent application number | Description | Published |
|---|---|---|
| 20090084496 | Method for fabricating a microfluidic component comprising at least one microchannel filled with nanostructures - A microfluidic component comprises at least one closed microchannel filled with nanostructures. The microchannel is produced by previously forming an opening delineating a bottom wall and two opposite side walls of the microchannel in a surface of a substrate. The nanostructures filling said microchannel are formed by in situ growth to constitute a layer of metallic catalyst deposited on said side walls and on said wall bottom. The microchannel is closed, before the nanostructures are formed, by sealing a protective cover onto said surface of the substrate. Sealing is obtained by formation of an eutectic compound between a material of the cover and the metal of the catalyst used for in situ growth of the nanostructures and deposited on the surface of the substrate designed to come into contact with the cover. | 04-02-2009 |
Agnes Gorce, Marseille FR
| Patent application number | Description | Published |
|---|---|---|
| 20110311598 | POWDERY EMULSIFYING COMPOSITION OF ALKYL POLYGLYCOSIDES, USE THEREOF FOR PREPARING COSMETIC EMULSIONS, AND METHOD FOR PREPARING SAME - A powdery composition C1 contains for 100% of the mass: 5 to 70 mass % and more particularly 10 to 50 mass % of at least one compound of formula (I): R—O-(G) | 12-22-2011 |
Agnes Gouble, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100144012 | USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF - A single chain homing endonuclease, comprising a first variant of I-CreI having the amino acid sequence of accession number pdb 1g9y and a second variant of I-CreI variant having the amino acid sequence of accession number pdb 1g9y in a single polypeptide. | 06-10-2010 |
| 20100146651 | MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM THE HPRT GENE AND USES THEREOF - An I-CreI variant or a single-chain derivative having at least one substitution in one of the two functional subdomains of the LAGLIDADG (SEQ ID NO: 153) core domain situated from positions 26 to 40 and 44 to 77 of I-CreI, and being able to cleave a DNA target sequence from the HPRT gene having a nucleotide sequence of SEQ ID NO: 1 to 14. Use of said variant for inducing a site-specific modification in the HPRT gene, for therapeutic (gene therapy of Lesch-Nyhan syndrome) or non-therapeutic purpose (engineering of transgenic animals and recombinant cell lines). | 06-10-2010 |
| 20100203031 | METHOD FOR ENHANCING THE CLEAVAGE ACTIVITY OF I-CREI DERIVED MEGANUCLEASES - A method for enhancing the cleavage activity of an I-CreI derived meganuclease, comprising the site-specific mutation of at least one amino acid residue which is selected in the group consisting of: the glycine at position 19, the phenylalanine at position 54, the phenylalanine at position 87, the serine at position 79, the valine at position 105 and the isoleucine at position 132 of I-CreI, and its application for the manufacturing of meganuclease cleaving a DNA target of interest, for use in genome therapy (treatment of genetic diseases) and genome engineering (making of transgenic animals, transgenic plants and recombinant cell lines). | 08-12-2010 |
| 20100325745 | MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM THE MOUSE ROSA26 LOCUS AND USES THEREOF - An I-CreI variant, wherein one of the two I-CreI monomers has at least two substitutions, one in each of the two functional subdomains of the LAGLIDADG (SEQ ID NO: 150) core domain situated respectively from positions 26 to 40 and 44 to 77 of I-CreI, said variant being able to cleave a DNA target sequence from the mouse ROSA26 locus. Use of said variant and derived products for the engineering of transgenic mice and recombinant mouse cell lines expressing an heterologous protein of interest. | 12-23-2010 |
| 20110091441 | MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM THE HUMAN INTERLEUKIN-2 RECEPTOR GAMMA CHAIN GENE AND USES THEREOF - An I-CreI variant, wherein at least one of the two I-CreI monomers has at least two substitutions, one in each of the two functional subdomains of the LAGLIDADG core domain situated respectively from positions 26 to 40 and 44 to 77 of I-CreI, said variant being able to cleave a DNA target sequence from the human IL2RG gene. Use of said variant and derived products for the prevention and the treatment of X-linked severe combined immunodeficiency. | 04-21-2011 |
| 20110151539 | USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF - A single chain homing endonuclease, comprising a first variant of I-CreI having the amino acid sequence of accession number pdb 1g9y and a second variant of I-CreI variant having the amino acid sequence of accession number pdb 1g9y in a single polypeptide. | 06-23-2011 |
| 20110287513 | USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF - A single chain homing endonuclease, comprising a first variant of I-CreI having the amino acid sequence of accession number pdb 1g9y and a second variant of I-CreI variant having the amino acid sequence of accession number pdb 1g9y in a single polypeptide. | 11-24-2011 |
Agnes Gruart I Masso, Sevilla ES
| Patent application number | Description | Published |
|---|---|---|
| 20090131339 | COMPOUNDS HAVING NEUROPROTECTIVE PROPERTIES - The invention relates to the use of morin and mangiferin, the pharmaceutically acceptable salts, prodrugs and/or solvates thereof in the production of a pharmaceutical composition for the prevention and/or treatment of a neurodegenerative disease and symptoms associated with ageing, as well as to food compositions comprising said compounds. | 05-21-2009 |
Agnes Hirschler-Rea, Aubagne FR
| Patent application number | Description | Published |
|---|---|---|
| 20080206839 | Use of Thermophilic Sulphate-Reducing Archaea For the Implementation of a Process For the Degradation of Hydrocarbons - The aim of the invention is to use sulphate-reducing thermophilic archaeobacteria for carrying out a method for degrading linear or branched, saturated or unsaturated, when necessary sulphur, aromatic hydrocarbons under anaerobic conditions. | 08-28-2008 |
Agnes Jaszenovics, Newark, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110300766 | Silicone Gel Seal And Method For Its Preparation And Use - A form stable gel may be used to make a seal between substrates to minimize air and moisture penetration. The form stable gel is useful in construction industry applications such as sealing window frame members, sealing retrofit and replacement windows, as well as indoor applications such as sealing bathtubs, sinks and shower surrounds. The form stable gel is also useful for sealing applications in boat hulls. | 12-08-2011 |
Agnes Keri, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20090130234 | Composition for the Treatment of Diabetic Periodontitis - The invention refers to the use of an extract of a part of a | 05-21-2009 |
| 20090214677 | Pharmaceutical Composition Containing an Extract of a Solidago Species - An extract of a part of a | 08-27-2009 |
Agnes Kim-Meade, Fanwood, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080279822 | Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand - The present invention relates to four distinct crystalline polymorphs of a monohydrate of Compound A having the following chemical structure: | 11-13-2008 |
Agnes Kulosa, Herne DE
| Patent application number | Description | Published |
|---|---|---|
| 20110070175 | USE OF ORGANOMODIFIED SILOXANE BLOCK COPOLYMERS AS CARE ACTIVE INGREDIENT FOR THE CARE OF HUMAN OR ANIMAL BODY PARTS - The present invention relates to the use of organomodified siloxane block copolymers as care active ingredient for the care of human or animal body parts. | 03-24-2011 |
Agnes Ladous, Charenton-Le-Pont FR
| Patent application number | Description | Published |
|---|---|---|
| 20120002162 | METHOD FOR CUTTING A PATCH TO BE APPLIED ONTO A CURVED SUBSTRATE - A method cuts a patch to be applied onto a curved substrate and includes the preliminary calculation of curvilinear lengths on the substrate between a reference point and a peripheral edge of said substrate. The calculated lengths are applied to a planar film for making the patch, and then the patch is cut by connecting the ends of the applied lengths. The patch then precisely coincides with the edge of the substrate. Such a method is particularly useful for applying a functional film onto a spectacle lens, as a trimming of the lens after the film is assembled with the lens would degrade said film. | 01-05-2012 |
Agnes Liu, Walnut, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100115426 | AVATAR ENVIRONMENTS - Embodiments are directed towards providing dynamic and interactive avatars of social networking members for use in visually displaying interactions and activities within a messaging context. A user interface is provided that enables relationships toy be displayed within a messaging context through automatic and/or dynamic grouping and/or re-arranging of avatars representing the member and a messaging user. Similar to, albeit it different from, an actual social event/party the dynamic displaying of members' avatars reflects how groups of people may interact. Thus, the disclosed embodiments provide a dynamic visual interface illustrating social congregation and interactions between members of a messaging social network. | 05-06-2010 |
Agnes Luty, New South Wales AU
| Patent application number | Description | Published |
|---|---|---|
| 20100028356 | METHOD OF DIAGNOSING A NEURODEGENERATIVE DISEASE - The present invention provides a method for diagnosing a neurodegenerative disease or for determining the predisposition of a subject to a neurodegenerative disease. In particular, the methods of the present invention comprise detecting a marker linked to map position 9p21, e.g., a marker within an opioid receptor sigma 1 (OPRS1) gene or an expression produce thereof. The present invention also provides a method for identifying new markers that are associated with a neurodegenerative disease. The present invention also provides mutant forms of an OPRS1 gene or an expression product thereof and reagents for detecting those mutations. | 02-04-2010 |
Agnes Moreau-Aubry, Nantes FR
| Patent application number | Description | Published |
|---|---|---|
| 20110212098 | Novel Melanoma Antigen Peptide and Uses Thereof - The present invention relates to novel melanoma antigen peptides and specific T lymphocytes directed to said peptides and the use thereof for treating melanoma. | 09-01-2011 |
Agnes Ostafin, Layton, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20090169866 | NANOCOMPOSITE MATERIALS WITH DYNAMICALLY ADJUSTING REFRACTIVE INDEX AND METHODS OF MAKING THE SAME - A concept and synthesis technology for a composite nanoparticle material which can be used to develop nanocomposite films and suspension with 1) dynamic refractive index control across a wide temperature and wavelength of light, and specified refractive index range, or 2) magnetic susceptibility or electronic conductivity over a wide temperature, magnetic field and electric field range. Core-shell nanoparticles can be made from two or more materials whose temperature dependent, electric field dependent or magnetic field dependent properties compensate one another will dynamically maintain a targeted refractive index, electronic conductivity or magnetic susceptibility over a specified temperature, electric and/or magnetic field range. Mixtures of composite nanoparticles with complementary behavior can optionally be used to widen the operational range of the nanocomposite material further or dampen temperature dependency in a controlled manner, e.g. using a non-random distribution of particles to affect a compensating gradient in the property of interest. | 07-02-2009 |
| 20110207232 | WATER SOLUBLE PH RESPONSIVE FLUORESCENT NANOPARTICLES - A nano-pH sensor can include a nanoparticle having an outer surface functionalized by a carboxy functional group. The nanoparticle is reversibly aggregated as a function of pH and is generally non-toxic. A fluorometer can be oriented to expose the nanoparticles to a light source at a given wavelength. Further, the fluorometer can be configured to detect changes in fluorescence of the gold nanoparticle with changes in pH. | 08-25-2011 |
| 20120077662 | Method And Apparatus For Continuous Removal Of Submicron Sized Particles In A Closed Loop Liquid Flow System - A method and apparatus for continuous removal of submicron sized artificial oxygen carriers (rAOC) and other materials such as cancer cells and bacteria from blood and other liquids. A centrifuge rotor having a curved shape is offset on a spinning rotor base and creates contiguous areas of low to high centrifugal force depending on the distances from the axis of the rotor base. This creates a density gradient field that separates materials of different densities input to the centrifuge that exit via different outputs. A monitor detects any red blood cells (RBC) with the rAOC before they exit the centrifuge. If there are any RBC detected logic circuitry changes the speed of rotation of the rotor, and the flow rate of pumps inputting and removing separated blood and rAOC to and from the centrifuge until there are no RBC in the rAOC exiting the centrifuge. | 03-29-2012 |
Agnes Pappne Behr, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20080280961 | New amino-alkyl-amide derivatives as CCR3 receptor ligands - The invention relates to a compound of the general formula (I), | 11-13-2008 |
| 20080280963 | New amino-alkyl-amide derivatives as CCR3 receptor ligands - The invention relates to a compound of the general formula (I), | 11-13-2008 |
| 20080287434 | New amino-alkyl-amide derivatives as CCR3 receptor ligands - The invention relates to a compound of the general formula (I), | 11-20-2008 |
| 20080293745 | New amino-alkyl-amide derivatives as CCR3 receptor ligands - The invention relates to a compound of the general formula (I), | 11-27-2008 |
Agnes Penaud, Mouans-Sartoux FR
| Patent application number | Description | Published |
|---|---|---|
| 20100293235 | METHOD AND SYSTEM FOR MANAGING THE ORDER OF MESSAGES - A method of ordering a plurality of messages received from a sender to be sent to a receiver in a sequence based on the dependency of one message on one or more other messages, the method comprising the steps of: receiving one or more messages from a stream of messages and storing them in a database; identifying a characteristic (P-Key-Order) of each message which is common to a group of messages; identifying a message dependency for the messages in the group of messages from a parameter of the message; reviewing a particular stored message in the database to determine if the stored message can be sent by; determining whether the stored message is dependent on a previous message and determining a status of the previous message; updating the status of the stored message based on the status of the previous message; sending the stored message after acknowledgement that the previous message has been sent. | 11-18-2010 |
Agnes Poulbot, Les Martres D'Artiere FR
| Patent application number | Description | Published |
|---|---|---|
| 20110277898 | TREAD WITH AN IMPROVED DRAINAGE SPACE - Tyre tread band ( | 11-17-2011 |
Agnes Princivalle, Lagnes FR
| Patent application number | Description | Published |
|---|---|---|
| 20100229542 | TEXTURIZED PURIFICATION STRUCTURE INCORPORATING AN ELECTROCHEMICAL CATALYST SYSTEM - A structure for the purification of a polluted gas comprising a porous matrix of an inorganic material, in the form of interconnected grains and an electrochemical system for the treatment of said gas, formed by a reduction catalyst A for reducing the polluting species of the NO | 09-16-2010 |
| 20110250112 | PURIFICATION STRUCTURE INCLUDING A CATALYSIS SYSTEM SUPPORTED BY A ZIRCON IN REDUCED STATE - The invention relates to a filtration structure, for filtering a gas coming from a diesel engine, which is laden with gaseous pollutants of the nitrogen oxide NO | 10-13-2011 |
Agnes Sandor, Meylan FR
| Patent application number | Description | Published |
|---|---|---|
| 20090265304 | METHOD AND SYSTEM FOR RETRIEVING STATEMENTS OF INFORMATION SOURCES AND ASSOCIATING A FACTUALITY ASSESSMENT TO THE STATEMENTS - A system and method for providing a factuality assessment of a retrieved information source's statement are disclosed. The method includes receiving a user's query which identifies an information source whose statements are to be retrieved, retrieving documents which refer to the information source, mapping statements in the retrieved documents to their authors, identifying as information source statements, the mapped statements that are mapped to an author which is compatible with the information source, and for at least one of the information source's statements, assessing a factuality of the information source's statement according to the information source. | 10-22-2009 |
Agnes Taillardat, Seewen So CH
| Patent application number | Description | Published |
|---|---|---|
| 20080213385 | Formulations for 7- (T-Butoxy) Iminomethyl Camptothecin - The present invention relates to nanoparticulate compositions in which the active agent is a topoisomerase I inhibitor and pharmaceutical compositions comprising the nanoparticulate compositions that are useful for the treatment and prevention of proliferative diseases including cancer. | 09-04-2008 |
| 20110028526 | VALSARTAN SOLID ORAL DOSAGE FORMS AND METHODS OF MAKING SUCH FORMULATIONS - The invention relates to melt granulation processes for preparing immediate release and sustained release pharmaceutical formulations comprising valsartan. | 02-03-2011 |
Agnes Taillardat, Seewen CH
| Patent application number | Description | Published |
|---|---|---|
| 20100022565 | PHARMACEUTICAL COMPOSITIONS - Provided is a pharmaceutical composition comprising a calcilytic agent which, when administered orally to a subject induces a rapid and short-lasting absorption of the calcilytic agent and/or a rapid and short-lasting release of the parathyroid hormone. | 01-28-2010 |
| 20100068265 | GELATIN CAPSULES COMPRISING AN ACID - A pharmaceutical composition in the form of a gelatin capsule comprising a pharmaceutically acceptable acid. | 03-18-2010 |
| 20110189286 | Pulsatile Release of Valsartan - The present invention provides gastroretentive pulsatile pharmaceutical delivery systems that improve the bioavailability of Valsartan wherein the medicament has improved solubility, improved residence time in the gastrointestinal tract and a pulsatile release profile. | 08-04-2011 |
Agnes Taman-Chardonnens, Bovenkarspel NL
| Patent application number | Description | Published |
|---|---|---|
| 20100170003 | Transgenic Plants with Increased Stress Tolerance and Yield - Polynucleotides are disclosed which are capable of enhancing a growth, yield under water-limited conditions, and/or increased tolerance to an environmental stress of a plant transformed to contain such polynucleotides. Also provided are methods of using such polynucleotides and transgenic plants and agricultural products, including seeds, containing such polynucleotides as transgenes. | 07-01-2010 |
Agnes Tamin, Brindas FR
| Patent application number | Description | Published |
|---|---|---|
| 20080230739 | Hydrofluorocarbon-Based Composition - The objective of the present invention is to provide a composition capable of being used as a refrigerant and which corresponds to the desire for a reduced environmental impact. | 09-25-2008 |
Agnes Tempez, Massy FR
| Patent application number | Description | Published |
|---|---|---|
| 20090309015 | NEUTRAL/ION REACTOR IN ADIABATIC SUPERSONIC GAS FLOW FOR ION MOBILITY TIME-OF-FLIGHT MASS SPECTROMETRY - The content of the invention comprises a concept of reactor for isolated ion transformations induced by collisions with neutral species. This reactor is also an interface between mobility cell and orthogonal injection TOFMS based on supersonic adiabatic gas flow with variable controlled composition directed along the axis of a multipole ion guide with sectioned rods for possibility of creating of controlled distributions of RF, DC and AC rotating fields. | 12-17-2009 |
| 20110291567 | DISCHARGE LAMP FOR GDS WITH AN AXIAL MAGNETIC FIELD - A glow discharge spectrometer discharge lamp includes: a lamp body having a vacuum enclosure connected to pump elements and to injector elements for injecting an inert gas into the enclosure; a hollow cylindrical first electrode of longitudinal axis X-X′; a second electrode for receiving a sample for analysis and for holding the sample facing one end of the cylindrical electrode; electric field generator including an applicator for applying to the terminals of the electrodes an electric field that is continuous, pulsed, radiofrequency, or hybrid, and suitable for generating a glow discharge plasma in the presence of the gas; coupler elements for coupling the discharge lamp to a spectrometer suitable for measuring at least one component of the plasma; and magnetic field generator elements for generating a magnetic field having field lines oriented along the axis X-X′, the magnetic field being uniform in orientation and in intensity over an area of the sample that is not less than the inside area of the hollow cylindrical electrode as projected along the direction X-X′. | 12-01-2011 |
Agnes Tempez, Houston, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20090140140 | MULTI-BEAM ION MOBILITY TIME-OF-FLIGHT MASS SPECTROMETRY WITH MULTI-CHANNEL DATA RECORDING - The content of the invention comprises a concept of multi-beam ion pre-selection from a single sample, coordinated mobility (against the gas flow) separation, cooling ions in supersonic gas flow and mass separation of thus low divergent ions by single or plural compact high-resolution orthogonal time-of-flight mass spectrometers both linear or reflectron type with controlled collision-induced dissociation (CID) and multi-channel data recording for the optimization of sample use in the analysis, and obtaining as much useful information about the sample as possible in a reasonably short time. | 06-04-2009 |
| 20100090101 | GOLD IMPLANTATION/DEPOSITION OF BIOLOGICAL SAMPLES FOR LASER DESORPTION TWO AND THREE DIMENSIONAL DEPTH PROFILING OF BIOLOGICAL TISSUES - The present invention enhances the laser desorption of biological molecular ions from surfaces by creating a surface localized MALDI particle matrix by ion implantation of low energy ionized clusters (gold, aluminum, etc.) or chemically derivatized clusters into the near surface region of the sample. MALDI analysis of the intact biomolecules on the surface or within a narrow subsurface region defined by the implantation range of the ions can then be performed by laser desorption into a mass spectrometer or, in a preferred embodiment, into a combined ion mobility orthogonal time of flight mass spectrometer. | 04-15-2010 |
Agnes Themens, Bourg La Reine FR
| Patent application number | Description | Published |
|---|---|---|
| 20090068238 | Cosmetic composition containing elastomers - The present invention relates to a solid anhydrous cosmetic composition comprising at least one non-spherical silicone elastomer and at least one silicone elastomer powder coated with a silicone resin. The invention also relates to a makeup process comprising the application to keratin materials of the said composition, and also to its use for obtaining a uniform makeup result that shows good fastness of the color over time. | 03-12-2009 |
Agnes Vercillo, Cicero, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080215363 | Tissue management system - The present invention provides a comprehensive tissue management system for transplantable materials like tissues and organs. The tracking portion of the system prompts and verifies that staff members of a medical establishment like a hospital have handled, stored, transported, reconstituted, and used the tissue or organ materials in a safe and regulatory-compliant manner from the point of receipt to the point of issuance or surgical use throughout the hospital's organization. The tracing portion of the system creates an integral record that documents which hospital staff members have provided which processing steps to the tissue or organ, any associated materials used in conjunction with such tissue or organ, and an identification of the tissue or organ that was transplanted or implanted inside a patient. Such a system will enable adverse reaction investigations for transplant patients, and recalls of transplantable materials. | 09-04-2008 |
Agnes Vermuelen, Cheminas FR
| Patent application number | Description | Published |
|---|---|---|
| 20110214201 | Method for Producing Haploid, Doubled Haploid and/or Dihaploid Plants by Gynogenesis - The invention relates to a method for producing haploid H, doubled haploid HD and/or dihaploid DH plants, the HD and DH being homozygous or essentially homozygous, this method being a method such as those which come under the technique of gynogenesis induced by irradiated pollen. This method comprises a step of irradiating the reproductive material of the male parent at a dose of between 160 and 190 gamma ray and/or a step of selecting the haploid H and/or DH plants by using one or more molecular marker(s). The invention also relates to a method for producing homozygous haploid, doubled haploid and/or dihaploid plants, comprising a step of determining the appropriate irradiation dose(s) for increasing the yields of said plants according to multiple given factors such as the plant species, the genotypes of the male parent and of the female parent, the climatic and weather conditions, the time at which the fruits are harvested, the level of growth of the embryos collected with a view to the culturing thereof, the level of development of the embryos placed in culture. Moreover, the invention concerns the molecular marker(s) used in the selection step and also the haploid embryos and the dihaploid embryos obtained by means of the method of the invention, and the progeny and the seeds of the plants obtained by means of the method of the invention. | 09-01-2011 |
Agnes Vignery, Branford, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20080213333 | Methods and compositions for fostering and preserving bone growth - A method for augmenting bone in a subject in need thereof including installing within an interior portion of a bone located in the subject a sufficient amount of a biocompatible material to form a scaffold within the bone interior, wherein the scaffold serves as a support for the formation of new bone within the bone interior portion, and administering to the subject a sufficient amount of at least one bone augmentation agent to elevate blood concentration of at least one anabolic agent in the subject. The method may further include administering at least one anti-resorptive agent to the subject in an amount sufficient to substantially prevent resorption of new bone growth. In another embodiment, the method may further include a step of mechanically inducing an increase in osteoblast activity in the subject, wherein the elevation in blood concentration of the anabolic agent and the increase in osteoblast activity at least partially overlap in time. | 09-04-2008 |
| 20100104582 | CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts - Disclosed are methods and compositions relating to CD200 and its receptor, CD200R which modulate bone mass via the differentiation of osteoclasts. | 04-29-2010 |
Agnes Zoldowski, Aurora CA
| Patent application number | Description | Published |
|---|---|---|
| 20090148849 | ONE-STEP TARGET DETECTION ASSAY - The present invention provides nucleic acid amplification, detection, and genotyping techniques. In one embodiment, the present invention provides a method for amplifying and detecting a target nucleic acid sequence by providing a first primer pair comprising: a first primer comprising a target specific sequence, a tag sequence 5′ of the target specific sequence, and a blocker between the target specific sequence and the tag sequence, and a second primer comprising a target specific sequence; providing a reporter attached to either the second primer or to a dNTP; providing a capture complex comprising an anti-tag sequence attached to a solid support; combining the first primer pair, the capture complex, the reporter, and a sample comprising a target nucleic acid sequence under conditions suitable for amplification of the target nucleic acid sequence and hybridization of the amplified target nucleic acid sequence to the capture complex; and detecting the amplified target nucleic acid sequence. | 06-11-2009 |
Agnes Zvara, Szeged HU
| Patent application number | Description | Published |
|---|---|---|
| 20080274455 | Use Of Genes As Molecular Markers In Diagnosis Of Schizophrenia And Diagnostic Kit For The Same - Drug-naive and drug-free schizophrenic PBL were screened to identify additional markers that are differentially expressed compared to healthy individuals using microarray and quantitative real-time PCR (QRT-PCR) techniques. Genes for dopamine D | 11-06-2008 |